Cefiderocol Sulfate Tosylate

硫酸甲苯磺酸头孢德罗

Report date: 2026/01/12 13:49:04
NMEQIDP

Base Information

Drug NameCefiderocol Sulfate Tosylate
Drug Alias Name头孢罗考cefiderocolum头孢德罗cefiderocolCefiderocol Sulfate Tosylate Hydrate +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsHospital-acquired pneumoniaPyelonephritisUrinary Tract Infections +[12] 
Global Approved IndicationsPyelonephritisUrinary Tract InfectionsGram-Negative Bacterial Infections +[4] 
Approved Indications in ChinaPyelonephritisUrinary Tract Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2019/11/14
Country/TerritoryCzechiaBelgiumCanada +[37] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNhs EnglandLink Medical Products Pty LtdClinigen Ltd +[9] 
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaPyelonephritisUrinary Tract Infections +[9] 
Inactive IndicationsPneumoniaHealthcare-Associated PneumoniaInfections

Other Information

ATC CodeJ01D
Related LinksWikipediaDrugBankKEGG